Inaugural CHERISH Pilot Grants Awarded
Karen Lasser, MD, MPH Dr. Lasser’s pilot grant proposes to evaluate economic and health outcomes for a primary care-based HCV treatment program in a patient-centered medical home. The treatment model is based on the chronic care model including a multidisciplinary team with physician, nursing, social worker, pharmacy technician and pharmacist. The team works together to […]
NIH Clarifies Priorities for Health Economics Research
The National Institutes of Health (NIH) recently released an announcement outlining funding priorities for health economics research. The announcement confirms that health economics methods can be instrumental in promoting the NIH mission to improve health and is an integral part of the interdisciplinary science that NIH supports. It goes on to clarify that NIH will prioritize […]
Quality of Life of Opioid Users and their Spouses
There are more deaths in the US from opioids than from any other unintentional injury–one person died every 30 minutes from an opioid analgesic overdose in the US in 2014. The experience of living with opioid use is harmful both for the opioid user and for his or her spouse. A recent study published in the journal Addiction quantified […]
CHERISH at CDUHR: Center-to-Center Collaboration Begins
On December 8th, CHERISH Director Dr. Bruce Schackman, delivered a presentation at the NIDA-funded located at the New York University College of Nursing. CDUHR Co-director and CHERISH Center Advisory Board Member Dr. Sherry Deren welcomed Dr. Schackman, who presented an overview of the mission, goals, and organization of CHERISH. Dr. Schackman highlighted the Methodology Consultation service offered by CHERISH […]
State Medicaid Spending on Sovaldi: Wide Variation in Spending and Utilization in 2014
With a price tag of $1,000 per pill and $84,000 for a 12-week course of Sovaldi (sofosbuvir), Gilead Sciences prompted widespread concern about whether its new treatment for hepatitis C (HCV) would bankrupt public and private payers. These concerns were particularly significant for state Medicaid programs, which face both limited state budgets and high HCV […]
Center for Health Economics of Treatment for Substance Users Is Established at Weill Cornell Medical College
The high costs of treating the more than 7 million people with a substance use disorder may be daunting to public and private payers. The costs of not treating them may be even higher, especially if you consider the costs of failing to screen for and treat HIV and hepatitis C in this population. Sorting […]
Engage with CHERISH
Submit a Consultation Request or Contact Us to learn more about how CHERISH can support your research or policy goals.